- Home
- STRK vs MRK Comparison
STRK vs MRK Comparison
Compare STRK & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRK
- MRK
- Stock Information
- Founded
- STRK 1989
- MRK 2000
- Country
- STRK United States
- MRK United States
- Employees
- STRK 1483
- MRK N/A
- Industry
- STRK
- MRK Biotechnology: Pharmaceutical Preparations
- Sector
- STRK
- MRK Health Care
- Exchange
- STRK NYSE
- MRK Nasdaq
- Market Cap
- STRK N/A
- MRK 198.5B
- IPO Year
- STRK N/A
- MRK N/A
- Fundamental
- Price
- STRK $120.44
- MRK $81.00
- Analyst Decision
- STRK
- MRK Buy
- Analyst Count
- STRK 0
- MRK 15
- Target Price
- STRK N/A
- MRK $113.71
- AVG Volume (30 Days)
- STRK 527.6K
- MRK 18.0M
- Earning Date
- STRK 04-30-2025
- MRK 07-29-2025
- Dividend Yield
- STRK N/A
- MRK 4.00%
- EPS Growth
- STRK N/A
- MRK 667.14
- EPS
- STRK N/A
- MRK 6.88
- Revenue
- STRK $463,456,000.00
- MRK $63,922,000,000.00
- Revenue This Year
- STRK N/A
- MRK $2.42
- Revenue Next Year
- STRK N/A
- MRK $5.77
- P/E Ratio
- STRK N/A
- MRK $11.77
- Revenue Growth
- STRK N/A
- MRK 4.10
- 52 Week Low
- STRK $79.25
- MRK $73.31
- 52 Week High
- STRK $95.00
- MRK $129.93
- Technical
- Relative Strength Index (RSI)
- STRK N/A
- MRK 54.36
- Support Level
- STRK N/A
- MRK $78.14
- Resistance Level
- STRK N/A
- MRK $83.07
- Average True Range (ATR)
- STRK 0.00
- MRK 1.84
- MACD
- STRK 0.00
- MRK 0.21
- Stochastic Oscillator
- STRK 0.00
- MRK 64.15
About STRK MICROSTRATEGY 8.00% SERIES A PERPETUAL STRIKE PFD
Strategy is a bitcoin treasury company and a provider of business intelligence services. It is designed to provide investors varying degrees of economic exposure to Bitcoin by offering a range of securities, including equity and fixed-income instruments. The company also provide industry AI-powered enterprise analytics software.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.